Ahmad, F. B. & Anderson, R. N. The leading causes of death in the US for 2020. JAMA 325, 1829–1830 (2021).
Article CAS PubMed PubMed Central Google Scholar
Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029–3030 (2021).
Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12–49 (2024).
Zavala, V. A. et al. Cancer health disparities in racial/ethnic minorities in the United States. Br. J. Cancer 124, 315–332 (2021).
Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin. 70, 7–30 (2020).
Sung, H., Wiese, D., Jatoi, I. & Jemal, A. State variation in racial and ethnic disparities in incidence of triple-negative breast cancer among US women. JAMA Oncol. 9, 700–704 (2023).
Article PubMed PubMed Central Google Scholar
American Cancer Society. Colorectal cancer facts & figures 2017–2019. cancer.org https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/colorectal-cancer-facts-and-figures/colorectal-cancer-facts-and-figures-2017-2019.pdf (2017).
Zimpelman, G. L. et al. Cancer in Alaska Native people: 1969–2018, the 50-year report (Alaska Native Tribal Health Consortium, Epidemiology Center, 2021).
Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233–254 (2023).
Crenshaw, K. Demarginalizing the intersection of race and sex: a black feminist critique of antidiscrimination doctrine, feminist theory and antiracist policies. Univ. Chic. Leg. Forum 1989, 8 (1989).
Peters, U. & Tomlinson, I. Utilizing human genetics to develop chemoprevention for cancer—too good an opportunity to be missed. Cancer Prev. Res. 17, 7–12 (2024).
Islami, F. et al. American Cancer Society’s report on the status of cancer disparities in the United States, 2021. CA Cancer J. Clin. 72, 112–143 (2022).
Khan, A. T. et al. Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: experiences from the NHLBI TOPMed program. Cell Genomics 2, 100155 (2022).
Article CAS PubMed PubMed Central Google Scholar
Popejoy, A. B. Too many scientists still say Caucasian. Nature 596, 463 (2021).
Rambachan, A. Overcoming the racial hierarchy: the history and medical consequences of “Caucasian”. J. Racial Ethn. Health Disparities 5, 907–912 (2018).
Mucci, L. A. et al. Familial risk and heritability of cancer among twins in nordic countries. JAMA 315, 68–76 (2016).
Article CAS PubMed PubMed Central Google Scholar
Lichtenstein, P. et al. Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85 (2000).
Article CAS PubMed Google Scholar
Barry, C.-J. S. et al. How to estimate heritability: a guide for genetic epidemiologists. Int. J. Epidemiol. 52, 624–632 (2023).
Hur, Y.-M. et al. Twin family registries worldwide: an important resource for scientific research. Twin Res. Hum. Genet. 22, 427–437 (2019).
Chan, T. F. et al. Estimating heritability explained by local ancestry and evaluating stratification bias in admixture mapping from summary statistics. Am. J. Hum. Genet. 110, 1853–1862 (2023).
Article CAS PubMed PubMed Central Google Scholar
Vinkhuyzen, A. A. E., Wray, N. R., Yang, J., Goddard, M. E. & Visscher, P. M. Estimation and partition of heritability in human populations using whole-genome analysis methods. Annu. Rev. Genet. 47, 75–95 (2013).
Article CAS PubMed PubMed Central Google Scholar
McClellan, J. & King, M.-C. Genetic heterogeneity in human disease. Cell 141, 210–217 (2010).
Article CAS PubMed Google Scholar
Li, M., He, Z., Tong, X., Witte, J. S. & Lu, Q. Detecting rare mutations with heterogeneous effects using a family-based genetic random field method. Genetics 210, 463–476 (2018).
Article PubMed PubMed Central Google Scholar
Tung, N. M. & Garber, J. E. BRCA1/2 testing: therapeutic implications for breast cancer management. Br. J. Cancer 119, 141–152 (2018).
Article CAS PubMed PubMed Central Google Scholar
Couch, F. J., Nathanson, K. L. & Offit, K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science 343, 1466–1470 (2014).
Article CAS PubMed PubMed Central Google Scholar
Soewito, S. et al. Disparities in cancer genetic testing and variants of uncertain significance in the hispanic population of South Texas. JCO Oncol. Pract. 18, e805–e813 (2022).
Article PubMed PubMed Central Google Scholar
Chrysafi, P. et al. Prevalence of variants of uncertain significance in patients undergoing genetic testing for hereditary breast and ovarian cancer and Lynch syndrome. Cancers 15, 5762 (2023).
Article CAS PubMed PubMed Central Google Scholar
Chern, J. Y., Lee, S. S., Frey, M. K., Lee, J. & Blank, S. V. The influence of BRCA variants of unknown significance on cancer risk management decision-making. J. Gynecol. Oncol. 30, e60 (2019).
Article PubMed PubMed Central Google Scholar
Caswell-Jin, J. L. et al. Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genet. Med. 20, 234–239 (2018).
Marlin, R. et al. Mutation HOXB13 c.853delT in Martinican prostate cancer patients. Prostate 80, 463–470 (2020).
Article CAS PubMed Google Scholar
Akbari, M. R. et al. Association between germline HOXB13 G84E mutation and risk of prostate cancer. J. Natl Cancer Inst. 104, 1260–1262 (2012).
Article CAS PubMed Google Scholar
Darst, B. F. et al. A rare germline HOXB13 variant contributes to risk of prostate cancer in men of African ancestry. Eur. Urol. 81, 458–462 (2022).
Article CAS PubMed PubMed Central Google Scholar
Na, R. et al. The HOXB13 variant X285K is associated with clinical significance and early age at diagnosis in African American prostate cancer patients. Br. J. Cancer 126, 791–796 (2022).
Article CAS PubMed Google Scholar
Oddoux, C. et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat. Genet. 14, 188–190 (1996).
Article CAS PubMed Google Scholar
Neuhausen, S. et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat. Genet. 13, 126–128 (1996).
Comments (0)